CPI is a leading independent technology innovation centre and founding member of the High Value Manufacturing Catapult. We bring innovative ideas and research to the marketplace through our experts, equipment, networks, and funding. We have capability spanning both the development of manufacturing ready processes for AMR therapeutics but also the development of in vitro diagnostics for clinical application. We can complete process development and toxicology supply for all modalities, from proteins, to antibodies, bacteriophage and microbiome-related products, and for diagnostics, cover all assay development, from reagent production and optimisation, through to instrumentation, software and firmware.